Brussels, Belgium, 2023.09.25 - Alant Health Sarl, trusted strategic and operational advisor for medical technology, is thrilled to announce its partnership with Neuroventis, an innovative company focused on digital health in neurology. This collaboration marks a significant step forward in advancing healthcare solutions through expert advising and industry exploration. By providing strategic guidance and industry insights, Alant Health will assist Neuroventis in navigating the landscape of healthcare, thus accelerating their growth trajectory.
Rhovica Neuroimaging wins CHF 150,000 to develop A catheter that reduces risk in lifesaving neurosurgical procedures.
Bern, Switzerland, 2022.12.29 Rhovica Neuroimaging is developing a new external ventricular drainage catheter (EVD). Called SoNav, it has integrated sensors allowing for the safe, fast, and cost-efficient catheter placement and monitoring of brain ventricles. Their product addresses the high risk of a common neurosurgical intervention. The startup was awarded CHF 150,000 as the winner of Venture Kick’s third stage [...]
DIXI Medical Reorganization
Chaudefontaine, France, 2019.01.04 - More than 40 years ago, DIXI Medical designed and manufactured its first deep electrode for SEEG. Today DIXIs’ products are marketed in more than 30 countries [...]
Réorganisation de DIXI Medical
Chaudefontaine, France, 2019.01.04 - Il y a plus de 40 ans que DIXI Medical a conçu et fabriqué sa première électrode profonde pour la SEEG. Aujourd'hui nos produits sont commercialisés dans plus de 30 pays [...]
AOT AG is a Finalist for the 2018 Red Herring Top 100 Europe Award
BASEL, Switzerland, 12.04.2018 – Advanced Osteotomy Tools AG (AOT AG) announced today it has been selected as a finalist for Red Herring's Top 100 Europe award, a prestigious list honoring the year’s most promising private technology ventures from the European business region [...]
G-ray Medical and CSEM are set to continue the development of the latenium™ technology
Hauterive, Neuchatel, Switzerland, 26 February 2018 - G-ray Medical Sàrl, a Neuchâtel startup, is currently developing an ultra-high performance detector dedicated to medical applications and in particular mammography. These ultra-high performance detectors will be made in partnership with CSEM, based on G-ray’s revolutionary lateniumTM technology. Centred on particle-counting X-ray imaging, this unique solution is set to improve the quality of the images obtained from examinations such as breast cancer screening helping earlier detection and reducing the radiation doses currently needed for mammography [...]
G-ray Switzerland appoints Dr Abed Hammoud to its Board of Directors
Hauterive, Switzerland, 15.06.2017 – G-ray Switzerland SA, an emerging leader in x-ray imaging technologies- based in Neuchâtel – strengthens its Board of Directors with the election of Dr Abed M. Hammoud. A seasoned international entrepreneur and top executive in medical technologies, Dr Hammoud brings G-ray an additional competitive edge with his comprehensive experience and deep knowledge of the medical imaging industry [...]
Technologies d'imagerie par rayons-X Abed Hammoud, DR, rejoint le Conseil d'administration de G-ray Switzerland SA
Hauterive, Switzerland, 15.06.2017 - G-ray Switzerland SA, start-up active dans le domaine de l'imagerie par rayons-X, renforce son Conseil d'administration avec la nomination du Dr Abed M. Hammoud, spécialiste des technologies médicales. Au bénéfice d'une grande et large expérience internationale dans les activités liées à l'imagerie médicale, il complète le Conseil de G-ray Switzerland SA constitué de personnalités industrielles, scientifiques, médicales et financières de premier plan [...]
G-ray Switzerland concludes collaborative research agreement with CERN
Neuchâtel, Switzerland, 22.05.2017 – G-ray Switzerland, a company developing leading edge particle detection systems, is pleased to announce that it has signed with CERN, the European Organization for Nuclear Research, an R&D collaboration agreement on characterisation of charge transfer process across low temperature bonded interfaces [...]
Renishaw neuromate® stereotactic robot to assist during surgery at Harvard (Boston Children’s Hospital) Epilepsy Center
May 2017 - Renishaw is pleased to announce that Boston Children’s Hospital (BCH) has become the 34th world leading health organization to have a neuromate® stereotactic robot installed. This installation is the 6th in the United States of America [...]
Renishaw neuromate® robot and neuroinspireTM planning software installed at Alder Hey Children's Hospital, UK
January 2017 - Renishaw is pleased to announce that a neuromate® stereotactic robot system and neuroinspire™ surgical planning software have been installed and used at Alder Hey Children’s Hospital, Liverpool [...]
Renishaw neuromate® robot and neuroinspireTM planning software installed at Birmingham Children's Hospital, UK
January 2017 - Renishaw is pleased to announce that a neuromate® stereotactic robot system and neuroinspire™ surgical planning software has been installed at one the UK’s leading specialist paediatric centres, the Birmingham Children’s Hospital [...]
Valtronic Celebrates EPFL Innovation Park Office Opening
LES CHARBONNIÈRES, Switzerland, June 16, 2016 - Valtronic has officially opened its Innovation Office in the Ecole Polytechnique Fédéral de Lausanne (EPFL) Innovation Park on June 6, 2016, in the presence of government officials, researchers, customers as well as academic and other partners [...]
Installation of a Neuromate® Robot for Stereotactic Surgery: Efforts to Conform to Japanese Specifications and an Approach for Clinical Use—Technical Notes
October 2015 - The neuromate® is a commercially available, image-guided robotic system for use in stereotactic surgery and is employed in Europe and North America. In June 2015, this device was approved in accordance with the Pharmaceutical Affairs Law in Japan. The neuromate® can be specified to a wide range of stereotactic procedures in Japan [...]
First Renishaw neuromate® robot installation and procedure in Spain
September 2015 - Renishaw is pleased to announce that a neuromate® stereotactic robotic system has been installed at the Neurosurgery Department of the renowned Hospital Quirón Teknon, in Barcelona. This is the first installation of neuromate® in Spain [...]
neuromate® frameless Gen II robot installation and first deep brain stimulation (DBS) performed in the USA at The Ohio State University Wexner Medical Center
July 2015 - Renishaw is pleased to announce that a neuromate® frameless Gen II stereotactic robotic system has been installed at the Department of Neurological Surgery at The Ohio State University Wexner Medical Center in Columbus, Ohio [...]
First Renishaw neuromate® frameless Gen II robot installation in the United States of America
April 2015 - Renishaw is pleased to announce that a neuromate® frameless Gen II stereotactic robotic system has been installed, at the neurosurgery department of the Thomas Jefferson University Hospital in Philadelphia. This is the first installation of neuromate® frameless Gen II in the USA [...]
Renishaw neuromate® robot installation in Cologne, Germany
April 2014 - Renishaw is pleased to announce that a neuromate® stereotactic robotic system has been installed at the the Department of Stereotaxy and Functional Neurosurgery of the University Hospital in Cologne, Germany [...]
First Renishaw neuromate® robot installation in Saudi Arabia
February 2014 - Renishaw is pleased to announce that its stereotactic neurosurgical robotic system, neuromate®, has received marketing authorisation for sale in the Kingdom of Saudi Arabia by the Saudi Food and Drug Authority. A neuromate® system has recently been installed and the first surgical procedures have been performed at the King Fahad Medical City Hospital in Riyadh. This is the first placement of a neurosurgical robot in the Kingdom of Saudi Arabia [...]
First Renishaw neuromate® robot installation in Qatar
October 2013 - Renishaw is pleased to announce that a neuromate® stereotactic robotic system has been delivered to Hamad Medical Center in Doha. This is the first installation of neuromate® in Qatar [...]
First surgical procedures for Renishaw’s neuromate® robot in Nice, France
December 2012 - Renishaw is pleased to announce that the Neurosurgery Department of Centre Hospitalier Universitaire Pasteur in Nice, France have now completed their first neurosurgical robotic procedures using Renishaw’s neurmate® stereotactic system [...]
Erste chirurgische Eingriffe des Renishaw Neuromate® - Roboters in Nizza, Frankreich
December 2012 - Das Unternehmen Renishaw freut sich bekannt zu geben, dass die neurochirurgische Abteilung der Universitätsklinik - Pasteur in Nizza, Frankreich die ersten roboter-assistierten neurochirurgischen Eingriffe mit Hilfe des stereotaktischen Systems neuromate® durchgeführt hat [...]
First Peruvian surgical procedure for Renishaw’s Neuromate® robot
May 2012 - Renishaw is pleased to announce that the first neurosurgical robotic procedure with its NeuroMate® stereotactic system has taken place at the Neurosurgery Department of Hospital Nacional Guillermo Almenara in Lima, Peru. This is the first South American installation of NeuroMate®, which provides cutting-edge robotic technology that enables neurosurgeons to deliver field proven neuro-implantable devices with pinpoint accuracy [...]
Renishaw acquires a 75% interest in Schaerer Mayfield NeuroMate AG and gains a solid foothold in the robot assisted neurosurgery market
24th November 2008 - As part of its continuing commitment to growing its presence in the neurosurgical market, Renishaw has acquired, for a cash consideration, a 75% stake in Schaerer Mayfield NeuroMate AG, based in Switzerland, and its wholly-owned subsidiary, Schaerer Mayfield NeuroMate Sarl, a leading manufacturer of surgical robots for neurosurgery, based in Lyon, France. The deal was completed on 20th November 2008 [...]
Renishaw acquires a 75% interest in Schaerer Mayfield NeuroMate AG
Renishaw expands its presence in the neurosurgical market by acquiring 75% interest in Schaerer Mayfield
Renishaw gains a solid foothold in the robot assisted neurosurgery market
As part of its continuing commitment to growing its presence in the neurosurgical market, Renishaw has acquired, for a cash consideration, a 75% stake in Schaerer Mayfield NeuroMate AG, based in Switzerland, and its wholly-owned subsidiary, Schaerer Mayfield NeuroMate Sarl, a leading manufacturer of surgical robots for neurosurgery, based in Lyon, France. The deal was completed on 20th November 2008 [...]
Inventing the Future
Northern Ohio Live - January 2001 - Probing minds - Cleveland neurosurgeons are pushing the boundaries of a new cerebral technologies.
By ANTON ZUIKER
Brain scan: A 3-D reconstruction of an MRI image of the brain of a patient who has received deep-brain stimulation treatment for tremor caused by Parkinson’s disease.
Over the cackle of static, Abed Hammoud whispers to me through his surgical mask: "This is the frontier of medical technology."
Hammoud is not a surgeon. He has a PhD in biomedical engineering and works for Medtronic Corporation. This snowy morning in December, he is in Operating Room Number Eleven at the Cleveland Clinic Foundation. He is operating the Silicon Graphics computer and Medtronic's software that is allowing Clinic neurosurgeons Ali Rezai and Erwin Montgomery to ever so slowly push an electrode the size of a hair deep into the brain of a man named Russell Purdue, in a procedure called deep brain stimulation (DBS) [...]
An internet-connected, patient-specific, deformable brain atlas integrated into a surgical navigation system.
Journal of Digital Imaging August 1997, Volume 10, Supplement 1, pp 231–237
We present a patient-specific deformable atlas that is easily integrated into our surgical navigation device. The atlas is a powerful new tool for the integration of information with the surgical act. This is the first time an outline atlas has been implemented to provide individualized, high- resolution data to the operating surgeon [...]
SOFAMOR DANEK ACQUIRES REMAINING STOCK OF SURGICAL NAVIGATION TECHNOLOGY.
MEMPHIS, Tenn.-- (BUSINESS WIRE)--April 30, 1996 -- Sofamor Danek Group, Inc. (NYSE:SDG) today announced that it has acquired the remaining 80.5% of the outstanding stock of Surgical Navigation Technology ("SNT") for an undisclosed amount. In March 1995, Sofamor Danek purchased 19.5% of the outstanding stock of SNT and acquired the exclusive worldwide license (except in Korea until 1997) to manufacture and distribute SNT products relating to frameless stereotactic surgery in spinal and neurological fields [...]
Image recovery from data acquired with a charge-coupled-device camera
Journal of the Optical Society of America A - Vol. 10, No. 5/May 1993
A model for data acquired with the use of a charge-coupled-device camera is given and is then used for developing a new iterative method for restoring intensities of objects observed with such a camera. The model includes the effects of point spread, photo-conversion noise, readout noise, nonuniform flat-field response, nonuniform spectral response, and extraneous charge carriers resulting from bias, dark current, and both internal and external background radiation. An iterative algorithm is identified that produces a sequence of estimates converging toward a constrained maximum-likelihood estimate of the intensity distribution of an imaged object. An example is given for restoring images from data acquired with the use of the Hubble Space Telescope [...]
This research was supported in part by the National Science Foundation under grant MIP-9101991 and the Division of Research Resources of the National Institutes of Health under grant RR001380. R. L. White appreciates the support of the Visiting Fellows Program at the Joint Institute for Laboratory Astrophysics of the University of Colorado. Figures 2 and 3 are based on observations with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555.